Mottola Frank bought SUPN
July 29, 2026 · Form 4 insider transaction
Mottola Frank bought 1,650 shares of Supernus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,650
Price
$0.00
Total value
N/A
InsiderMottola Frank
Role—
SecurityPerformance Share Unit
Transaction codeA: Grant or award
Transaction dateJuly 29, 2026
Filing dateJuly 31, 2026
Shares owned after1,650
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.